NEWS
Product exhibitions, press releases, company updates, etc.
Partnership to Offer CLIA-Waived Hematology Analyzer to U.S. Customers
Henry Schein Enters Exclusive Distribution Agreement with CytoChip
CitoCBC delivers rapid, lab-quality hematology results — right at the point of care.
Join CytoChip at ADLM 2025 – Booth #1363
CytoChip Receives FDA Clearance and First CLIA Waiver for a Cartridge-Based Complete Blood Count Test
First CLIA Waiver
07
2026-01
16
2025-07
We’re excited to showcase CitoCBC®, the first cartridge-based CBC device to receive both FDA 510(k) clearance and a CLIA Waiver.
26
2025-02
The CLIA-waived CitoCBC expands patient access to quick CBC results in physician offices, pharmacies, and home care, enabling data-driven diagnostics. News Provided By CytoChip Inc. February 25, 2025
17
2024-12
Analytical performance of a point-of-care CBC hematology analyzer, including a 5-part differential
A performance study of CytoChip's cBc device in CLlA Waiver settings has been published in AcJP.
15
2022-08
Completed 3rd investment round of $8.5M.
